Guangzhou Baiyunshan (China) Today
| 600332 Stock | 29.01 0.30 1.04% |
Performance6 of 100
| Odds Of DistressLess than 9
|
Guangzhou Baiyunshan is trading at 29.01 as of the 1st of December 2024, a 1.04 percent increase since the beginning of the trading day. The stock's open price was 28.71. Guangzhou Baiyunshan has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat modest performance during the last 90 days. Equity ratings for Guangzhou Baiyunshan Pharmaceutical are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Moving together with Guangzhou Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Guangzhou Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Guangzhou Baiyunshan's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Guangzhou Baiyunshan or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Executive Chairman | Ning CPA |
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Guangzhou Baiyunshan Pharmaceutical (600332) is traded on Shanghai Stock Exchange in China and employs 28,048 people. Guangzhou Baiyunshan is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 44.07 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Guangzhou Baiyunshan's market, we take the total number of its shares issued and multiply it by Guangzhou Baiyunshan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Guangzhou Baiyunshan operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 1.41 B outstanding shares.
Guangzhou Baiyunshan generates positive cash flow from operations, but has no cash available
Check Guangzhou Baiyunshan Probability Of Bankruptcy
Ownership AllocationGuangzhou Baiyunshan Pharmaceutical has a total of 1.41 Billion outstanding shares. Guangzhou Baiyunshan secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Guangzhou Ownership Details
Guangzhou Baiyunshan Risk Profiles
Although Guangzhou Baiyunshan's alpha and beta are two of the key measurements used to evaluate Guangzhou Baiyunshan's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.36 | |||
| Semi Deviation | 1.78 | |||
| Standard Deviation | 2.09 | |||
| Variance | 4.39 |
Guangzhou Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Guangzhou Baiyunshan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
| All Next | Launch Module |
Guangzhou Baiyunshan Corporate Directors
| Changhai Wu | Deputy Director | Profile | |
| Zhang Chunbo | Executive Director | Profile | |
| Juyan Liu | Executive Director | Profile | |
| Hong Li | GM Director | Profile |
Other Information on Investing in Guangzhou Stock
Guangzhou Baiyunshan financial ratios help investors to determine whether Guangzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangzhou with respect to the benefits of owning Guangzhou Baiyunshan security.